Drug companies push new products really hard. Just before Prozac became available in generic form, meaning Eli Lilly and Company was losing its patent on it, they developed a slow release, once-a-week version so they could still market the drug (one of the most popular for depression) under a patent and make a mint on it. My doctor told me that the Eli Lilly reps offered all-expenses-paid trips to doctors who could successfully move patients from the daily (which was going generic, and thus quite inexpensive) to the new patented version. In his office, which is quite large, the "target" to get yourself a trip was successfully moving 100 patients over to the weekly product. I asked him if that was a challenge, and he said that in a large practice like his, it really isn’t. He’s one of the partners in the practice, and he said he could easily, with almost no effort, have moved that many patients to the weekly if he had wanted to. He didn’t want to, because he’s not convinced the mechanism is quite as effective at treating depression as a daily drug is. Despite that, other doctors in his practice pushed the new drug, and went on trips.

It seems drug companies are very interested in pushing their new drugs–new patients with prescriptions in hand mean money in their pockets. But there’s a catch with moving so fast. Here’s an example:

http://news.yahoo.com/s/hsn/vioxxsheartrisklingeredlongafteruseended

Different drug, same problem. Bextra was pushed so hard I had it offered to me for an amazing array of things. It was first offered to me for menstrual pain the month after it came on the market. It was offered again and again for various pains, and when my main pain problem was diagnosed as fibromyalgia, that was the only drug the rheumatologist would consider giving me. Luckily for me, it never worked for me, so I never took it for more than two weeks.

Which leads to my main question. Who is responsible for these drugs which can cause long term damage and problems? Is it the drug companies who are required to do testing before the FDA will approve the drug for patient use? Are they not being careful enough in their testing by not testing for long-term effects? Or is it the FDA, for not forcing more stringent testing requirements?

I have several friends who rode the Phen-Fen train, and ended up with heart damage. I have a friend whose mother had a debilitating stroke after taking Vioxx for just six months. And I know more than one person who attempted suicide as a teen after they were given second-generation depression drugs like Zoloft and Paxil. (One actually has a sibling who was given the same drug and did commit suicide.) Those drugs are now labeled as having increased risk for teens and kids.

So, who’s to blame? And what can consumers do when doctors are generally so eager to prescribe the newest medicines, which may not be safe?

I’d love to hear your thoughts.

Thank you.